AL-15469A for the Treatment of Bacterial Conjunctivitis.
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Infectious conjunctivitis
- Focus Therapeutic Use
- Sponsors Alcon
- 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2007 Status changed from recruiting to in progress.
- 06 Oct 2006 New trial record.